Crispr Therapeutics Ag (NQ: CRSP )
45.74 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Mar 17, 2023 Add to My Watchlist
All News about Crispr Therapeutics Ag
Here's How Much $100 Invested In CRISPR Therapeutics 5 Years Ago Would Be Worth Today
August 31, 2022
CRISPR Therapeutics (NASDAQ:CRSP) has outperformed the market over the past 5 years by 16.43% on an annualized basis producing an average annual return of 26.37%. Currently, CRISPR Therapeutics has a...
Benzinga's Top Ratings Upgrades, Downgrades For August 9, 2022
August 09, 2022
MarketBeat: Week in Review 8/1 - 8/5
August 06, 2022
The hot jobs report is dispelling any notion that interest rates will level off. But the market moves on and here are some of the stocks and stories to follow.
Topics Economy Electric Vehicles
Exposures Electric Vehicles Interest Rates
Cathie Wood Sheds $5M In CRISPR Therapeutics, Scoops Up These Biotech Stocks Instead
August 05, 2022
Cathie Wood-led Ark Investment Management on Thursday sold 70,723 shares of gene editing company CRISPR Therapeutics AG (NASDAQ: CRSP), valued at over $5.58 million, via its flagship fund.
Evercore ISI Group downgraded its rating of CRISPR Therapeutics (NASDAQ:CRSP) to In-Line with a price target of $60.00, changing its price target from $66.00 to $60.00. Shares of CRISPR Therapeutics...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following